English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The article studies the normative legal regulation of distribution and accountability of medicines and medical products (MP) in healthcare institutions and its features that are typical for medical and preventive institutions (MPI). It has been found what groups of medicines should be subjected to the strict record keeping and storage in MPI, and the list of accounting operations for medicines and MP (receiving, storage, dispensing (transfer), disposal) has been determined. The accounting process of medicines and MP from receiving in MPI to delivery to the patient has been analyzed. The need of its division into several components, namely inventory control of medicines and MP; accountability of medicines and MP in the hospital departments; accountability of medicines and MP at the post (in procedure rooms); accounting of medicines and MP, has been identified. It has been determined that each component performs a special task to meet the storage conditions, expiration date, control over the use and reporting. It has been found that in addition to the analytical accounting in MPI the bookkeeping adapted for the budget organization activities within the current legislation is also carried out. The analysis has shown that the current legal regulation of medicines and MP under the conditions of MPI generally covers the whole range of measures for their distribution. It has been determined that the failure to carry out certain measures makes it impossible to control the entire way of medicines and MP from the moment MPI receive them till the patient uses them.

Analysis of the normative legal regulation of accountability of medicines and medical products in healthcare institutions